Fingolimod HCl (Generic for Gilenya)

Introducing Fingolimod HCl formulated to the Gilenya standard—an immunomodulatory agent that sequesters lymphocytes within lymph nodes to reduce central nervous system inflammation. This targeted therapy effectively lowers relapse rates and slows disease progression, providing enhanced neuroprotection, reduced inflammatory activity, and improved mobility.